PerioPredict® Genetic Risk Test Incorporated into Freedom Dental Plan
WALTHAM, Mass., April 21, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic diseases and health-related conditions, today announced it has …